Serial 88645842
Live / Registered — Registered (as of 19 Jan 2021)
What this means for you
Registered since 19 Jan 2021. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (the §8 declaration of use was filed 03 Sept 2026 and is awaiting the USPTO's acceptance).
Record
- Serial number
- 88645842
- Registration number
- 6252397
- Mark type
- Design / logo
- Filed
- 08 Oct 2019
- Published for opposition
- 12 May 2020
- Registered
- 19 Jan 2021
- Next maintenance filing
- §8 declaration of use, filed 03 Sept 2026 — awaiting the USPTO's acceptance
- Attorney of record
- Kumiko Ide
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of the central nervous system disorders; pharmaceutical preparations for the treatment of Parkinson's disease, Alzheimer's disease, depression, anxiety, movement disorders, memory impairment, brain disorder and brain dysfunction
Owner
- Kyowa Kirin Co., Ltd., Tokyo, JP
- Kyowa Kirin Co., Ltd., Tokyo, JP
- Kyowa Kirin Co., Ltd., Tokyo, JP
Prosecution history
- 03 Sept 2026 — TEAS SECTION 8 & 15 RECEIVED
- 19 Jan 2026 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 19 Jan 2021 — REGISTERED-PRINCIPAL REGISTER
- 15 Dec 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 14 Dec 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 25 Nov 2020 — STATEMENT OF USE PROCESSING COMPLETE
- 16 Nov 2020 — USE AMENDMENT FILED
- 25 Nov 2020 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 16 Nov 2020 — TEAS STATEMENT OF USE RECEIVED
- 07 Jul 2020 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 12 May 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 12 May 2020 — PUBLISHED FOR OPPOSITION
- 22 Apr 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 01 Apr 2020 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 18 Mar 2020 — TEAS/EMAIL CORRESPONDENCE ENTERED